Search Results | Litt's Drug Eruption and Reaction Database

Drugs belonging to restart save

class – mTOR inhibitor – 3 items found

show all
0–9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Adverse reactions attributed to entire drug class 'mTOR inhibitor'

Please login to view adverse reactions.

Acneiform eruption / acneiform dermatitis / acneiform rash

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367>10% [REVIEW]

Cutaneous toxicity / skin toxicity

(2015): Macdonald JB+, J Am Acad Dermatol 72(2), 221 [REVIEW]
(2015): Somers MJ+, J Clin Pharmacol 55(4), 368 [REVIEW]
(2014): Grellety T+, Bull Cancer (French) 101(6), 608
(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW] (ovarian)

(2014): Caletti C+, G Ital Nefrol (Italian) 31(4), Epub

Peripheral edema

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367>10% [REVIEW]

Wound complications

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367 [REVIEW]
(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

Oral ulceration

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367>10% [REVIEW]

Stomatitis (oral mucositis)

(2017): Vigarios E+, Support Care Cancer 25(5), 1713 [REVIEW]
(2015): Shameem R+, Cancer Invest 33(3), 7034%
(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]
(2013): Boers-Doets CB+, Future Oncol 9(12), 1883 [REVIEW]

(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

Diabetes mellitus (includes type 1 and type 2 diabetes mellitus)

(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367>10% [REVIEW]
(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

Hypercholesterolemia

(2016): Lew S+, Anticancer Res 36(4), 1711 [REVIEW]
(2014): Murakami N+, Am J Transplant 14(10), 2317 [REVIEW]

Hyperglycemia (includes glucose increased)

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367 [REVIEW]
(2016): Lew S+, Anticancer Res 36(4), 1711 [REVIEW]
(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

Hypertriglyceridemia (includes triglycerides increased)

(2016): Lew S+, Anticancer Res 36(4), 1711 [REVIEW]

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367 [REVIEW]

Sexual dysfunction

(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]
(2014): Murakami N+, Am J Transplant 14(10), 2317 [REVIEW]

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367>10% [REVIEW]

(2014): Caletti C+, G Ital Nefrol (Italian) 31(4), Epub

(2015): Fusco V+, Clin Genitourin Cancer 13(4), 287 [REVIEW]

Nephrotoxicity / kidney injury / acute kidney injury (AKI) / drug-induced kidney injury

(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367>10% [REVIEW]
(2014): Kaplan B+, Transplant Rev (Orlando) 28(3), 126 [REVIEW]
(2014): Murakami N+, Am J Transplant 14(10), 2317 [REVIEW]

(2017): Fernandes-Silva G+, Expert Opin Drug Metab Toxicol 13(4), 367 [REVIEW]

Pulmonary toxicity

(2016): Willemsen AE+, Int J Cancer 138(10), 2312 [REVIEW]
(2014): Caletti C+, G Ital Nefrol (Italian) 31(4), Epub

(2016): Sadowski K+, Pharmacol Rep 68(3), 536 [REVIEW]

Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere